MERRIMACK PHARMACEUTICALS IN (MACK) Stock Analyst Ratings
NASDAQ:MACK - Nasdaq - US5903282094 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 45% to MACK. The Buy consensus is the weighted average rating of the current analysts ratings.
MACK was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about MACK.
In the previous month the buy percentage consensus was at a similar level.
MACK was analyzed by 8 analysts. More opinions would make the average more meaningful.